Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 28Gastric Adenocarcinoma 4Sarcopenia 2Recurrence 1Peritoneal Neoplasms 1Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer 1Osteoporosis 1Obesity, Abdominal 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Margins of Excision 1Locally Advanced Gastric Carcinoma 1Locally Advanced Gastric Cancer 1Hypertension 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Diabetes Mellitus 1Coitus 1Advanced Gastric Cancer 1Adenocarcinoma 1

Interventions

Oxaliplatin 10Gemcitabine 8Cisplatin 7Hepatectomy 6Fluorouracil 6Radiofrequency Ablation 5Liver Transplantation 5Irinotecan 5Capecitabine 5lenvatinib 4Paclitaxel 4Neoadjuvant Therapy 4Folfox protocol 4Cetuximab 4Aspirin 4tislelizumab 3Surgical Procedures, Operative 3Nivolumab 3Carboplatin 3titanium silicide 2durvalumab 2apatinib 2Trastuzumab 2S 1 (combination) 2Leucovorin 2Lamivudine 2Introns 2Ethiodized Oil 2Drug Therapy 2DNA, Mitochondrial 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Gastrectomy × Gastrointestinal × Clear all
NCT02313688 2017-12-11

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

West China Hospital

Phase NA Unknown
320 enrolled
Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡